Bourg la Reine, France

François Lemonnier

USPTO Granted Patents = 6 


Average Co-Inventor Count = 4.7

ph-index = 2

Forward Citations = 29(Granted Patents)


Company Filing History:


Years Active: 2006-2018

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: François Lemonnier: Innovator in Transgenic Research

Introduction

François Lemonnier is a notable inventor based in Bourg la Reine, France. He has made significant contributions to the field of transgenic research, particularly in the development of innovative methods and applications involving transgenic mice. With a total of 6 patents to his name, Lemonnier's work has implications for therapeutic advancements in immunology and oncology.

Latest Patents

Lemonnier's latest patents include groundbreaking inventions such as transgenic mice having a human major histocompatibility complex (MHC) phenotype. This invention relates to transgenic mice and isolated transgenic mouse cells that comprise a disrupted H2 class I gene and a disrupted H2 class II gene, along with functional HLA class I and class II transgenes. These transgenic mice are designed to be deficient in both H2 class I and class II molecules, which allows for advanced experimental uses in immunological research.

Another significant patent involves mutated immunogenic peptides derived from the R9M sequence. This invention focuses on optimizing the wild R9M peptide for therapeutic vaccination against leukemia in humans. It includes polynucleotides coding for the mutated peptides, cellular expression vectors, and antibodies that can be used for vaccine preparation and immune response stimulation.

Career Highlights

Throughout his career, François Lemonnier has worked with prestigious institutions such as the Institut Pasteur and the Institut National de la Santé et de la Recherche Médicale. His research has been pivotal in advancing the understanding of immune responses and developing new therapeutic strategies.

Collaborations

Lemonnier has collaborated with notable colleagues in his field, including Pierre Langlade-Demoyen and Yu-Chun Lone. These collaborations have further enriched his research and contributed to the success of his innovative projects.

Conclusion

François Lemonnier's contributions to transgenic research and immunology are significant, with a focus on developing innovative solutions for therapeutic applications. His work continues to influence the field and pave the way for future advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…